Greater uncertainty was revealed for 1 individual with MSH2/MSH6-deficient EC associated with a single somatic variant in MSH2 identified by tumor-normal sequencing and a personal history of MMR-proficient CRC. The gene discussed is MSH2; the disease is neoplasm.